ReviewPharmaceutics2025
Molecular Design of Novel Protein-Degrading Therapeutics Agents Currently in Clinical Trial.
Ela Kacin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewPharmaceutics2025
Ela Kacin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.